Two Seas Capital »

Immunovant shares owned by Two Seas Capital

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Two Seas Capital from 13F filings

Historical chart of Two Seas Capital investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Two Seas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Two Seas Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $20M 514k 38.39

More positions owned by Two Seas Capital

Indivior Ord (INDV)
Roivant Sciences SHS (ROIV)
Immunovant (IMVT)
Arbutus Biopharma (ABUS)
3M Company (MMM)
Meta Platforms Cl A (META)
Esperion Therapeutics Inc Ne Note 4.000%11/1 (Principal)
Esperion Therapeutics (ESPR)
Sonos (SONO)
Odyssey Marine Expl Com New (OMEX)
Hertz Global Hldgs Com New (HTZ)
Arcutis Biotherapeutics (ARQT)
Hertz Global Hldgs *w Exp 06/30/205 (HTZWW)

View all positions for Two Seas Capital

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant